MiR-1207-5p targets PYCR1 to inhibit the progression of prostate cancer

Bray, 2018, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, Ca - Cancer J. Clin., 68, 394, 10.3322/caac.21492 Baade, 2013, Epidemiology of prostate cancer in the Asia-Pacific region, Prostate international, 1, 47, 10.12954/PI.12014 Scher, 2004, Targeting the androgen receptor: improving outcomes for castration-resistant prostate cancer, Endocr. Relat. Canc., 11, 459, 10.1677/erc.1.00525 Gomella, 2014, Current management of advanced and castration resistant prostate cancer, Can. J. Urol., 21, 1 Bartel, 2009, MicroRNAs: target recognition and regulatory functions, Cell, 136, 215, 10.1016/j.cell.2009.01.002 Pasquinelli, 2012, MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship, Nat. Rev. Genet., 13, 271, 10.1038/nrg3162 Li, 2015, miR-494-3p regulates cellular proliferation, invasion, migration, and apoptosis by PTEN/AKT signaling in human glioblastoma cells, Cell. Mol. Neurobiol., 35, 679, 10.1007/s10571-015-0163-0 Chae, 2019, MiR-195 and miR-497 suppress tumorigenesis in lung cancer by inhibiting SMURF2-induced TGF-β receptor I ubiquitination, Molecular oncology, 13, 2663, 10.1002/1878-0261.12581 Yan, 2020, CircHIPK3 promotes colorectal cancer cells proliferation and metastasis via modulating of miR-1207-5p/FMNL2 signal, Biochem. Biophys. Res. Commun., 524, 839, 10.1016/j.bbrc.2020.01.055 Hou, 2019, miR-1207-5p regulates the sensitivity of triple-negative breast cancer cells to Taxol treatment via the suppression of LZTS1 expression, Oncol Lett, 17, 990 Dang, 2016, miR-1207-5p suppresses lung cancer growth and metastasis by targeting CSF1, Oncotarget, 7, 32421, 10.18632/oncotarget.8718 Das, 2016, miR-1207-3p is a novel prognostic biomarker of prostate cancer, Translational oncology, 9, 236, 10.1016/j.tranon.2016.04.005 Das, 2016, miR-1207-3p regulates the androgen receptor in prostate cancer via FNDC1/fibronectin, Exp. Cell Res., 348, 190, 10.1016/j.yexcr.2016.09.021 Das, 2017, A novel microRNA-1207-3p/FNDC1/FN1/AR regulatory pathway in prostate cancer, RNA & disease (Houston, Tex.), 4 Feng, 2017, Screening the key microRNAs and transcription factors in prostate cancer based on microRNA functional synergistic relationships, Medicine, 96, 10.1097/MD.0000000000005679 Li, 2017, Effect of R119G mutation on human P5CR1 dynamic property and enzymatic activity, BioMed Res. Int., 2017, 4184106 Sang, 2019, Pyrroline-5-Carboxylate reductase 1 accelerates the migration and invasion of nonsmall cell lung cancer in vitro, Cancer Biother. Radiopharm., 34, 380 Yan, 2019, Knockdown of PYCR1 inhibits proliferation, drug resistance and EMT in colorectal cancer cells by regulating STAT3-Mediated p38 MAPK and NF-κB signalling pathway, Biochem. Biophys. Res. Commun., 520, 486, 10.1016/j.bbrc.2019.10.059 Zhuang, 2019, PYCR1 interference inhibits cell growth and survival via c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathway in hepatocellular cancer, J. Transl. Med., 17, 343, 10.1186/s12967-019-2091-0 Zeng, 2017, Knockdown of PYCR1 inhibits cell proliferation and colony formation via cell cycle arrest and apoptosis in prostate cancer, Medical oncology (Northwood, London, England), 34, 27, 10.1007/s12032-016-0870-5 Jariwala, 2007, Identification of novel androgen receptor target genes in prostate cancer, Mol. Canc., 6, 39, 10.1186/1476-4598-6-39 Yang, 2015, miRNA-1207-5p is associated with cancer progression by targeting stomatin-like protein 2 in esophageal carcinoma, Int. J. Oncol., 46, 2163, 10.3892/ijo.2015.2900 Chen, 2014, miR-1207-5p and miR-1266 suppress gastric cancer growth and invasion by targeting telomerase reverse transcriptase, Cell Death Dis., 5, 10.1038/cddis.2013.553 Ye, 2018, Pyrroline-5-carboxylate reductase 1 promotes cell proliferation via inhibiting apoptosis in human malignant melanoma, Canc. Manag. Res., 10, 6399 Gao, 2020, PYCR1 knockdown inhibits the proliferation, migration, and invasion by affecting JAK/STAT signaling pathway in lung adenocarcinoma, Mol. Carcinog., 59, 503, 10.1002/mc.23174